Cell Expansion Market Size, Share, By Product (Instruments, Consumables, and Disposables), Cell Type (Mammalian Cells and Microbial Cells), Application (Oncology Research, Stem Cell Research, Gene Therapy, Vaccine Production, Tissue Culture & Engineering, Drug Development, and Others), End-User (Research Institute, Biotechnology & Biopharmaceutical Companies, Cell Banks, and Others), and Region - Trends, Analysis, and Forecast till 2035

• Cell expansion market size is expected to reach USD 53.5 Billion by 2035.
• In 2024, the market for cell expansion market was worth at USD 15.2 Billion.
• The market is rising at a CAGR of 13.5%.

Cell expansion is the process where a cell increases in size, primarily through the intake of water and other substances, without undergoing cell division. Cell expansion is artificial production of daughter cells from single cell, to support medical research. Cell expansion requires the synthesis of new cell wall material and controlled loosing of the cell wall allowing it to stretch and increase in area. Increasing research and development activities for the use of cell therapy technique for the development of vaccines, therapeutics and antibiotics. Cell expansion is used in drug screening, drug development, resulting to drive cell expansion market growth.

Impact of AI on Cell Expansion Market:

Artificial intelligence (AI) is significantly driving cell expansion market by enabling more efficient and precise cell culture monitoring to optimize cell growth conditions. AI algorithms can analyze large datasets of optimal cell expansion parameters, such as media composition, temperature, and passage number, leading to improvement in cell quality and yield. Machine learning can identify patterns in manufacturing data to optimize cell expansion processes leading to reduce the variability of cells.

Key Drivers of Target Market:

Increasing Healthcare Investment and Funding Fuels Market Growth

Increasing healthcare investment and funding provide the financial resources and incentives for continued innovation, development, and commercialization of advanced cell therapies. Rising government funding for regenerative medicine, stem cell research, and personalized therapies is leading to growth of target market. The biopharmaceutical companies are heavily investing in cell-based therapies to develop advanced cell therapies such as, CAR-T and advancing technologies to expand culture cells in large quantities for clinical use, resulting to drive cell expansion market growth.

• For instance, in February 2025, Pluri secures USD 3.5 million investment in cell-based biotechnology sector. This new funding, coming from long-term shareholder Merchant Adventure Fund, is a follow-up to a previous USD 6.5 million placement and brings total recent financings to USD 10 million. This investment focuses on advancing Pluri’s 3D cell expansion technology, which is aimed to create scalable and cost-effective cell-based solutions.

Restraints:

Safety Concerns and Risk of Contamination Disrupt Market Expansion

Cell-based therapies involve handling of live cells, there is high risk of microbial contamination lead to further infection when introduced in the human body. The risk of contamination is particularly high when scaling up from laboratory conditions to large-scale commercial production, where maintaining a sterile environment becomes increasingly complex. Contamination trigger unwanted immune response in patient, leading to complication in treatment, resulting to disrupt growth of cell expansion market.

• Counterbalance Statements: Advances in molecular biology and genomic techniques to allow more precise contamination detection in earliest stage. Set up quality assurance protocols to monitor cell line health throughout the expansion process and detect abnormality that could affect the safety. Use of single-use disposable equipment to reduce chances of cross-contamination.

Opportunities & Market Trends:

Advancement in Cell and Gene Therapy is Expected to Drive Market Growth

Advancement in cell and gene therapy involves manipulating cells or genes to treat diseases in genetic disorders, cancer treatment and regenerative medicine. Regenerative medicine field, focuses on repairing or replacing of damaged tissues and organs with the help of cell and gene therapy, which is highly depend on cell expansion technologies. Increasing demand for personalized medicine, significantly improve patient-specific cell production therapies through cell expansion system, resulting to drive cell expansion market growth in upcoming years.

• For instance, in February 2025, PHC Corporation collaborated with CCRM for the development of primary T-cell expansion culture processes to accelerate the manufacturing of cell and gene therapy products. This collaboration focused on integration of LiCellGrow cell expansion system for regenerative medicine and bio manufacturing to establish new culture processes to improve cell culture efficiency and quality of cell & gene therapy products.

The cell expansion market is segmented into product, cell type, application, end-user, and region.

Product:

Based on product, the market is categorized into instruments, consumables, and disposables. The consumables holds the largest cell expansion market share due to the availability of wide range of commercial media and reagent products for biopharmaceutical companies. Consumable products are convenient, ready to use, and are also available in serum-free formulation, leading to growth of cell expansion market size. 

• For instance, in May 2023, Lonza launched the TheraPEAK T-VIVO Cell Culture Medium with a novel chemically defined formulation developed to optimize and streamline CAR T-cell manufacturing. It is free from animal components, and aimed to improve consistency and process control of cell expansion and simplifies regulatory approval for faster time-to-market.

Cell Type:

The target market, by cell type, is segmented into mammalian cells and microbial cells. The mammalian cells are expected to dominate the target market. Mammalian cells play crucial role in biotechnology applications, particularly in biopharmaceutical production and gene therapies. Rising research activities for the development of cell-based therapeutics such as regenerative medicine and cell & gene therapies. The increasing adoption of human cells for manufacturing of cell-based therapeutics, resulting to drive cell expansion market growth.

Application:

By application, cell expansion market is categorized into, oncology research, stem cell research, gene therapy, vaccine production, tissue culture & engineering, drug development, and others. The oncology research dominates in target market share due to growing need for cancer therapies, such as immunotherapies, gene therapies and cell-based treatment, leading to demand for cell expansion technologies. Cell expansion play crucial role in T-cell therapies and tumor-infiltrating lymphocyte therapies, to expand for use in clinical treatment, resulting to drive cell expansion market size.

• For instance, in January 2025, Researchers at the University of Pittsburgh developed new way to grow T cells in the lab that enables the cells to live longer and destroy cancer cells in a mouse model of melanoma, as compared to using traditional growth media. This study used small molecule od Dichloroacetate (DCA) in the T cells during in vitro expansion of cells, to improve cell metabolism, stemness and survival of T cell in cancer, resulted in better antitumor efficiency in mice.

End-User:

Based on end-user, the target market is classified into research Institute, biotechnology & biopharmaceutical companies, cell banks, and others. The biotechnology & biopharmaceutical companies segment holds largest cell expansion market share. These companies involve extensive research & development for the development of new-generation therapeutics, which require cell expansion techniques. The increasing research activities by commercial organization to develop efficient vaccines and Gene Therapy is anticipated to the market expansion.

Region:

Geographically, the market is studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America: North America is the dominating region with the largest revenue share of 36.1%, for the cell expansion market due to the adoption of advanced healthcare solutions in the U.S. the government agencies, which is accelerating the manufacturing of stem cells and development of regenerative medicine. Increasing research and development in cell and gene therapy, resulting to drive cell expansion market size.

• For instance, in January 2024, STEMCELL Technologies announced the acquisition with Propagenix Inc., focused on developing technologies for new regenerative medicine. The Propagenix’s EpiX Technology got licensed to the STEMCELL for research use applications. This technology has the potential to address clinical needs to replace damaged tissues including, skin & intestinal tissue with engineered tissue solutions.

Asia Pacific: This region is the expected to be the fastest growing region for the target market due to the rise in pharmaceutical & biotechnological industries in China and India. Increasing government initiative in stem and gene therapy research have boosted the demand for advanced technologies, resulting to drive cell expansion market growth in upcoming years.

• For instance, in September 2022, Alkem Laboratories launched cell therapy StemOne in India. It is the first allogenic cell therapy product was approved by the approval from Drug Controller General of India (DCGI) for the commercial use in India for Knee OA.

Cell Expansion Market Report Scope:

Segmentation:

By Product:

• Instruments
  • Automated Cell Expansion System
  • Centrifuges
  • Bioreactors
  • Cell Counters
  • Dynabeads
  • Others
• Consumables
  • Reagents
  • Media & Serum
• Disposables
  • Bioreactor Accessories
  • Tissue Culture Flasks

By Cell Type:

• Mammalian Cells
  • Human Cells
    • Stem Cells
      • Induced Pluripotent Stem Cells
      • Adult Stem Cells
      • Embryonic Stem Cells
      • Differentiated Cells
      • Animal Cells
• Microbial Cells

By Application:

• Oncology Research
• Stem Cell Research
• Gene Therapy
• Vaccine Production
• Tissue Culture & Engineering
• Drug Development
• Others

By End-User:

• Research Institute
• Biotechnology & Biopharmaceutical Companies
• Cell Banks
• Others

 By Region:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Russia
  • Italy
  • Spain
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • Indonesia
  • Malaysia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East & Africa

The key players operating in the cell expansion market include Merck KGaA, Danaher, Thermo Fisher Scientific Inc. and others. These key players are focusing on improving on research and development, innovative strategies, new product launches, strategic partnerships and acquisitions to enhance their product offering through collaborations.

List of Key Players in the Market:

• Merck KGaA
• Danaher
• Thermo Fisher Scientific
• Tofflon Life Science
• Miltenyi Biotech
• BD
• Agilent Technologies, Inc.
• F. Hoffmann-La Roche Ltd
• Lonza
• Terumo Corporation
• Eppendorf SE
• Bio-Techne
• STEMCELL Technologies
• Takara Bio Inc.
• Corning Incorporated

• In January 2025, Terumo Blood and Cell technologies collaborated with FUJIFIM Irvine Scientific to accelerate T cell expansion using Fujifilm’s PRIME-XV T Cell Expansion Media on Terumo BCT’s Quantum Flex Cell Expansion System. Terumo BCT’s protocols are aimed to reduce challenges associated with T cell expansion such as time, cost, and complexity of creating procedure. Fujifilm’s PRIME-XV T Cell Expansion Media, used in combination with Terumo BCT’s Quantum Flex Cell Expansion System, to offer a reliable, reproducible option for expanding T cells at production scale.
• In March 2024, the U.S. Food and Drug Administration (FDA) approved Bristol Myers Squibb’s Breyanzi, a CD19-directed chimeric antigen receptor (CAR) T cell therapy. This therapy aimed for the treatment of adult patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who have received at least two prior lines of therapy. This CAR T cell therapies represent a transformative treatment option for patients with blood cancer.

Analyst View:

Cell Expansion are used in various sectors, including biotechnology, pharmaceutical, clinical diagnostics and regenerative medicine. The growing demand for precision medicine, advancement in cell-based therapies and rising focus on stem cell research, leading to growth of cell expansion market size.

More Related Reports

Cell Cryopreservation Market
Cell and Gene Therapy Manufacturing Market
Cell Culture Market
CAR-T Cell Therapy Market
Cell Culture Monitoring Biosensor Market